DBV Technologies to Participate in Upcoming AAAAI 2023 Congress

February 21, 2023

https://www.globenewswire.com/news-release/2023/02/21/2612739/0/en/DBV-Technologies-to-Participate-in-Upcoming-AAAAI-2023-Congress.html

Montrouge, France, February 21, 2023

DBV Technologies to Participate in Upcoming AAAAI 2023 Congress

DBV Technologies (Euronext:DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced upcoming participation at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Scientific meeting, taking place February 24-27 in San Antonio, TX. Two scientific poster presentations have been accepted on efficacy and safety data from subgroups of patients from the Phase 3 EPITOPE study. DBV will also host a booth in the AAAAI exhibit hall (#1826).

Read more at globenewswire.com

Related news for (DBVT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.